AI-generated summary
The authors compared transcutaneous magneto-laser treatment, added to drug therapy, with drug therapy alone and with drug therapy plus low-intensity laser in children and adolescents aged 5 to 17 with chronic gastritis. They report that magneto-laser therapy produced significantly greater improvement in clinical and morphological characteristics than drug therapy alone, with no significant difference from low-intensity laser.
- Who or what was studied
- Children and adolescents aged 5 to 17 years with chronic gastritis, allocated to three groups of 25 persons each
- Limits stated in the abstract
- The abstract does not report the wavelengths used, follow-up duration, or statistical details beyond the stated significance comparisons.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.